Survival times of women with metastatic breast cancer starting first-line chemotherapy in routine clinical practice versus contemporary randomised trials.
about
Physician experiences and preferences in the treatment of HR+/HER2- metastatic breast cancer in the United States: a physician surveyPrognosis for patients with metastatic breast cancer who achieve a no-evidence-of-disease status after systemic or local therapy.Doxorubicin-Loaded 70-150 μm Microspheres for Liver-Dominant Metastatic Breast Cancer: Results and Outcomes of a Pilot Study.
P2860
Survival times of women with metastatic breast cancer starting first-line chemotherapy in routine clinical practice versus contemporary randomised trials.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Survival times of women with m ...... ontemporary randomised trials.
@en
type
label
Survival times of women with m ...... ontemporary randomised trials.
@en
prefLabel
Survival times of women with m ...... ontemporary randomised trials.
@en
P2093
P2860
P356
P1476
Survival times of women with m ...... ontemporary randomised trials.
@en
P2093
E S Thientosapol
L Chantrill
M R Stockler
S A Della-Fiorentina
P2860
P304
P356
10.1111/IMJ.12178
P577
2013-08-01T00:00:00Z